Literature DB >> 3229477

Comparison of human lung surface protein profiles from the central and peripheral airways sampled using two regional lavage techniques.

S F Smith1, A Guz, A J Winning, N T Cooke, G H Burton, T D Tetley.   

Abstract

This study describes two new techniques of lung lavage which selectively remove material from the central airways, or from the lung below the seventh generation. Bronchograms confirmed that discrete regions of the lung were washed by central lavage (CL; maximum airway diameter approximately 6.5 mm) and peripheral lavage (PL; maximum airway diameter approximately 1.3 mm), and that both could be clearly distinguished from conventional bronchoalveolar lavage (BAL). These techniques were used to establish whether or not large-airway proteins made a major contribution to the protein profile of BAL. Twenty consecutive patients undergoing routine fibreoptic bronchoscopy were investigated. More bronchial mucus proteinase inhibitor per unit albumin and per unit total measured antiproteinase was present in CL than PL or BAL. In contrast alpha 1-proteinase inhibitor per unit albumin and as a percentage of total measured antiproteinase was lower in CL than in other lavage types. There were no differences in elastase activity, irrespective of the way in which the data were expressed. As no differences were found between BAL and PL for any of the variables measured, it was concluded that in the subjects studied the contribution of CL proteins to BAL was minimal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3229477

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  Microlavage: a technique for determining the volume of epithelial lining fluid.

Authors:  D R Baldwin; R Wise; J M Andrews; D Honeybourne
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

3.  Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.

Authors:  C Vogelmeier; R C Hubbard; G A Fells; H P Schnebli; R C Thompson; H Fritz; R G Crystal
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

4.  Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.

Authors:  Thomas P Lodise; Martina Kinzig-Schippers; George L Drusano; Ulrich Loos; Friedrich Vogel; Jürgen Bulitta; Markus Hinder; Fritz Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

5.  Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.

Authors:  M Maruyama; J G Hay; K Yoshimura; C S Chu; R G Crystal
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 6.  Oxidants, antioxidants, and respiratory tract lining fluids.

Authors:  C E Cross; A van der Vliet; C A O'Neill; S Louie; B Halliwell
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

7.  The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome.

Authors:  Yi Ren; Qing-Yu He; Jianqing Fan; Brian Jones; Yuan Zhou; Yi Xie; Chung-Yan Cheung; Adrian Wu; Jen-Fu Chiu; J S Malik Peiris; Paul Kwong Hang Tam
Journal:  Proteomics       Date:  2004-11       Impact factor: 3.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.